PatrickWilliamBurkeMD

PubMed

• Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up.
  Christy J Khouderchah, Lydia L Benitez, Bernard L Marini, Martina Fraga, Kristen Pettit, Patrick W Burke, Dale L Bixby, Anthony J Perissinotti> ;Leukemia & Lymphoma. 2024 Feb 1
• Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of Michigan.
  Charles E Foucar, Daniel H Foley, Jessica Aldous, Patrick W Burke, Kristen R Pettit, Lydia L Benitez, Anthony J Perissinotti, Bernard L Marini, Philip Boonstra, Dale L...> ;European Journal of Haematology. 2024 Mar 1
• 2 citations
  A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
  Keith W Pratz, Jason Kaplan, Moshe Levy, Dale Bixby, Patrick W Burke, Harry Erba, Trisha M Wise-Draper, Gail J Roboz, Nikolaos Papadantonakis, Trivikram Rajkhowa, Dani...> ;Haematologica. 2023 Mar 1
• Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase.
  YeeAnn Chen, Kaitlyn Buhlinger, Anthony J Perissinotti, Allison J Schepers, Lydia Benitez, Jessica Auten, Sheh-Li Chen, Dale L Bixby, Patrick W Burke, Kristen M Pettit...> ;Leukemia & Lymphoma. 2022 Nov 1
• 3 citations
  Oncology stewardship in acute myeloid leukemia.
  Madeleine A Ochs, Bernard L Marini, Anthony J Perissinotti, Charles E Foucar, Kristen Pettit, Patrick Burke, Dale L Bixby, Lydia L Benitez> ;Annals of Hematology. 2022 Aug 1
• 1 citations
  Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia.
  Madeleine A Ochs, Bernard L Marini, Lydia L Benitez, Sarah E Stump, Taylor M Weis, Kaitlyn M Buhlinger, Thomas Diaz, Justin H Reid, Benyam Muluneh, Kristen Pettit, Pat...> ;Leukemia & Lymphoma. 2022 Aug 1
• 1 citations
  Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation-A single institution...
  Radhika Takiar, Charles E Foucar, Anthony J Perissinotti, Bernard L Marini, Lydia Benitez-Colon, Patrick W Burke, Dale L Bixby> ;Leukemia Research Reports. 2022 Jan 1
• Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leuk...
  Alina Varabyeva, Christabel Pui-See Lo, Adamo Brancaccio, Anthony J. Perissinotti, Twisha S Patel, Katie Sandison, Lydia L. Benitez, Kristen Pettit, Patrick W. Burke, ...> ;Infection Control and Hospital Epidemiology. 2021 Oct 18
• 78 citations
  Acute lymphoblastic leukemia, version 2.2021
  Patrick A. Brown, Bijal D. Shah, Anjali S. Advani, Patricia Aoun, Michael Boyer, Patrick W. Burke, Daniel J. DeAngelo, Shira Dinner, Amir T. Fathi, Jordan Gauthier, Ni...> ;Journal of the National Comprehensive Cancer Network. 2021 Sep 1
• 1 citations
  Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study.
  Brian Bazzell, Bernard L. Marini, Lydia L. Benitez, Dale L. Bixby, Patrick W. Burke, Kristen Pettit, Anthony J. Perissinotti> ;Journal of Oncology Pharmacy Practice. 2021 Jun 1
• 8 citations
  Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia.
  Lydia L. Benitez, Anthony J. Perissinotti, Caitlin R. Rausch, Jeff Klaus, Stephen M Clark, Michael Filtz, Kelley L Ratermann, Carissa Treptow, Shawn Griffin, Marissa O...> ;Leukemia & Lymphoma. 2021 Apr 8
• 4 citations
  Utility of methicillin-resistant staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML).
  Millicynth Talagtag, Twisha S Patel, Gianni B. Scappaticci, Anthony J. Perissinotti, Allison J Schepers, Lindsay A Petty, Kristen Pettit, Patrick W. Burke, Dale L. Bix...> ;Transplant Infectious Disease. 2021 Apr 7
• 5 citations
  Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts.
  Justin H Reid, Anthony J. Perissinotti, Lydia L. Benitez, Daniel F. Boyer, Winston Y Lee, Patrick W. Burke, Kristen Pettit, Dale L. Bixby, Bernard L. Marini> ;Leukemia Research. 2021 Feb 19
• 4 citations
  Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia.
  Madeleine A. Ochs, Anthony J. Perissinotti, Bernard L. Marini, Patrick W. Burke, Dale L. Bixby, Kristen Pettit, Lydia L. Benitez> ;Leukemia Research. 2021 Mar 1
• 1 citations
  Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia.
  Justin H Reid, Bernard L. Marini, Lydia L. Benitez, Kristen Pettit, Dale L. Bixby, Patrick W. Burke, Anthony J. Perissinotti> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jan 19
• 22 citations
  Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
  Patrick W. Burke, Dieter Hoelzer, Jae H. Park, Kjeld Schmiegelow, Dan Douer> ;ESMO Open. 2020 Oct 1
• 3 citations
  Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis.
  Justin H Reid, Anthony J. Perissinotti, Lydia L. Benitez, Dale L. Bixby, Patrick W. Burke, Kristen Pettit, Bernard L. Marini> ;Leukemia & Lymphoma. 2020 Mar 20
• 3 citations
  Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21....
  Lauren E. Merz, Anthony J. Perissinotti, Bernard L. Marini, Patrick W. Burke, Ashley Crouch, Harry P. Erba, Dale L. Bixby> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Jan 1
• 6 citations
  Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia
  Fares Alsawah, Lydia L. Benitez, Sarah Choi, Bernard L. Marini, Anthony J. Perissinotti, Amy Skyles, Patrick W. Burke, Kristen Pettit, Ashley Crouch, Heather Fox, Dale...> ;Blood Advances. 2019 Nov 12
• 1 citations
  Mini‐HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?
  Bernard L. Marini, Anthony J. Perissinotti, Dale L. Bixby, Patrick W. Burke, Kristen Pettit, Lydia L. Benitez> ;Cancer. 2019 Nov 1
• 22 citations
  A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage
  Bernard L. Marini, Julia Brown, Lydia L. Benitez, Emily Walling, Raymond J. Hutchinson, Rajen Mody, Rama Jasty Rao, Lynn Slagle, Lauren Bishop, Kristen Pettit, Dale L....> ;Leukemia & Lymphoma. 2019 May 17
• 31 citations
  The leukemia strikes back: a review of pathogenesis and treatment of secondary AML
  Edna Cheung, Anthony J. Perissinotti, Dale L. Bixby, Patrick W. Burke, Kristen Pettit, Lydia L. Benitez, Julia Brown, Gianni B. Scappaticci, Bernard L. Marini> ;Annals of Hematology. 2019 Jan 21
• 17 citations
  The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia.
  Vera Vulaj, Anthony J. Perissinotti, James R. Uebel, Victoria R Nachar, Gianni B. Scappaticci, Ashley Crouch, Dale L. Bixby, Patrick W. Burke, Ivan Maillard, Moshe Tal...> ;Leukemia Research. 2018 Jul 1
• 17 citations
  PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia †.
  Caitlin R. Rausch, Bernard L. Marini, Lydia L. Benitez, Allison Elias, Patrick W. Burke, Dale L. Bixby, Anthony J. Perissinotti> ;Leukemia & Lymphoma. 2018 Mar 4
• 25 citations
  Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subseq...
  Patrick W. Burke, Ibrahim Aldoss, Matthew A. Lunning, Sean M. Devlin, Martin S. Tallman, Vinod Pullarkat, Ann M. Mohrbacher, Dan Douer> ;Leukemia Research. 2018 Mar 1
• Join now to see all

Abstracts/Posters

• Multi-Center Retrospective Evaluation of High-Dose Cytarabine Based Induction Versus CPX-351 Induction in Patients with Secondary AML
  Patrick W. Burke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019